Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.
Abstract
Parkinson's disease has been identified as a risk factor for severe Coronavirus disease 2019 (COVID-19) outcomes. However, whether the significant high risk of death from COVID-19 in people with Parkinson's disease is specific to the disease itself or driven by other concomitant and known risk factors such as comorbidities, age, and frailty remains unclear.
Citations
Altmetric:
Date
2023-07-31
Type
Article
Subject
Neurology, Respiratory medicine, Communicable diseases
Collections
Citation
PLoS One . 2023 Jul 31;18(7):e0285349
Journal / Source Title
PLoS ONE
DOI
10.1371/journal.pone.0285349
PMID
37523365
Publisher
Public Library of Science
Publisher’s URL
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389727/
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0285349
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0285349